+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Infections with the MERS coronavirus--for the present no threat to Europe

Infections with the MERS coronavirus--for the present no threat to Europe

Medizinische Monatsschrift für Pharmazeuten 38(12): 509-511

In Saudi Arabia, a novel coronavirus named Middle East respiratory syndrome coronavirus (MERS-CoV) was isolated in 2012 from patients with severe respiratory symptoms. Up to now, more than 1600 MERS cases have been registered mainly in the Arabian Peninsula. MERS is usually accompanied with fever, cough, and shortness of breath. In many cases, pneumonia is observed. However, clinical features of MERS range from mild disease to acute respiratory distress syndrome and multiorgan failure resulting in death, especially in individuals with underlying comorbidities. To date, about one in three people died as a result of MERS. In Europe, MERS cases have only been registered in isolated travelers entering from the Middle East.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 058106041

Download citation: RISBibTeXText

PMID: 26837158

Related references

Neutralizing the MERS coronavirus threat. Science Translational Medicine 6(235): 235fs19, 2014

MERS-CoV: Understanding the Latest Human Coronavirus Threat. Viruses 10(2):, 2018

Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity. Clinical Microbiology and Infection 22(10): 880-886, 2016

An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus. Journal of Infectious Diseases 209(2): 236-242, 2014


Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature. Journal of Hospital Infection 101(1): 20-29, 2019

Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014. Euro Surveillance 19(21):, 2014

Complete Genome Sequence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) from the First Imported MERS-CoV Case in China. Genome Announcements 3(4):, 2015

Extensive Viable Middle East Respiratory Syndrome (MERS) Coronavirus Contamination in Air and Surrounding Environment in MERS Isolation Wards. Clinical Infectious Diseases 63(3): 363-369, 2016

Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection. Journal of Infectious Diseases 213(10): 1557-1561, 2016

A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV. Journal of Virology 92(18):, 2018

Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. Journal of Virology 87(14): 7790-7792, 2013

Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. Proceedings of the National Academy of Sciences of the United States of America 111(34): 12516-12521, 2014

Computational modeling of the bat HKU4 coronavirus 3CL pro inhibitors as a tool for the development of antivirals against the emerging Middle East respiratory syndrome (MERS) coronavirus. Journal of Molecular Recognition 30(11):, 2017

Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia. Bmc Infectious Diseases 16: 174, 2016